Histogen Inc. (HSTO) Tops Q1 EPS by 59c

Histogen Inc. (NASDAQ: HSTO) reported Q1 EPS of ($0.81), $0.59 better than the analyst estimate of ($1.40). Revenue for the quarter came in at $0 , versus $0 reported last year.

For earnings history and earnings-related data on Histogen Inc. (HSTO) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• Methanex to idle Trinidad Titan plant after gas contract talks fail
• Bernstein SocGen on UnitedHealth Group (UNH): 'Expecting a strong 2Q driven by MA and potential for guidance raise'